Skip to content
← Back to this collection

PUBLICATIONS · 26527782

Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2016 Jan 20
First author
Joensuu H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Joensuu H
      type
      Author
    2. name
      Eriksson M
      type
      Author
    3. name
      Sundby Hall K
      type
      Author
    4. name
      Reichardt A
      type
      Author
    5. name
      Hartmann JT
      type
      Author
    6. name
      Pink D
      type
      Author
    7. name
      Ramadori G
      type
      Author
    8. name
      Hohenberger P
      type
      Author
    9. name
      Al-Batran SE
      type
      Author
    10. name
      Schlemmer M
      type
      Author
    11. name
      Bauer S
      type
      Author
    12. name
      Wardelmann E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Joensuu H
      type
      Author
    2. name
      Eriksson M
      type
      Author
    3. name
      Sundby Hall K
      type
      Author
    4. name
      Reichardt A
      type
      Author
    5. name
      Hartmann JT
      type
      Author
    6. name
      Pink D
      type
      Author
    7. name
      Ramadori G
      type
      Author
    8. name
      Hohenberger P
      type
      Author
    9. name
      Al-Batran SE
      type
      Author
    10. name
      Schlemmer M
      type
      Author
    11. name
      Bauer S
      type
      Author
    12. name
      Wardelmann E
      type
      Author
    bibliography ids
    1. nci-bib-bb6a058045ae533dd776b5c1
    book metadata
    content sha256
    15892a2286fe10781b78c4f61a1fba77b8d99157b8ef3929afef029379fb45c3
    document type
    citation
    dois
    1. 10.1200/JCO.2015.62.9170
    electronic publication date
    display
    2015 Nov 2
    precision
    day
    year
    2015
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26527782
    immutable id
    pubmed:26527782@15892a2286fe10781b78c4f61a1fba77b8d99157b8ef3929afef029379fb45c3
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    3
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    244-50
    volume
    34
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26527782
      provenance
      batch id
      948d34b0dea86780a31d
      provider
      NCBI PubMed ESummary
      record sha256
      bad7a2d8d8c17cfc208df96be3c005133439ccef4beb65585e60c697e5d40d11
      response sha256
      11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
      retrieved at
      2026-09-09T23:47:15.495091+00:00
      publication date
      display
      2016 Jan 20
      precision
      day
      year
      2016
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26527782/
      title
      Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

      Preserved source evidence · Not medical advice